help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehman, N. L.
Right arrow Articles by Jackson, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehman, N. L.
Right arrow Articles by Jackson, P. K.
(American Journal of Pathology. 2007;170:1793-1805.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060767

Oncogenic Regulators and Substrates of the Anaphase Promoting Complex/Cyclosome Are Frequently Overexpressed in Malignant Tumors

Norman L. Lehman*{dagger}, Rob Tibshirani{ddagger}, Jerry Y. Hsu§, Yasodha Natkunam*, Brent T. Harris*{dagger}, Robert B. West*, Marilyn A. Masek*, Kelli Montgomery*, Matt van de Rijn* and Peter K. Jackson*§

From the Departments of Pathology,* Health Research and Policy, and Statistics,{ddagger} the Division of Neuropathology,{dagger} and the Program in Cancer Biology,§ Stanford University, Stanford, California

The fidelity of cell division is dependent on the accumulation and ordered destruction of critical protein regulators. By triggering the appropriately timed, ubiquitin-dependent proteolysis of the mitotic regulatory proteins securin, cyclin B, aurora A kinase, and polo-like kinase 1, the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase plays an essential role in maintaining genomic stability. Misexpression of these APC/C substrates, individually, has been implicated in genomic instability and cancer. However, no comprehensive survey of the extent of their misregulation in tumors has been performed. Here, we analyzed more than 1600 benign and malignant tumors by immunohistochemical staining of tissue microarrays and found frequent overexpression of securin, polo-like kinase 1, aurora A, and Skp2 in malignant tumors. Positive and negative APC/C regulators, Cdh1 and Emi1, respectively, were also more strongly expressed in malignant versus benign tumors. Clustering and statistical analysis supports the finding that malignant tumors generally show broad misregulation of mitotic APC/C substrates not seen in benign tumors, suggesting that a "mitotic profile" in tumors may result from misregulation of the APC/C destruction pathway. This profile of misregulated mitotic APC/C substrates and regulators in malignant tumors suggests that analysis of this pathway may be diagnostically useful and represent a potentially important therapeutic target.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
T. Fujita, W. Liu, H. Doihara, H. Date, and Y. Wan
Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
Clin. Cancer Res., April 1, 2008; 14(7): 1966 - 1975.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.